SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex, Inc., a private spinal technology company, today announced it has named Earl R. Fender President and Chief Executive Officer and Member of the Board of Directors.
Mr. Fender brings over 25 years of successful leadership experience in general management and product commercialization in the medical device and spinal industry. During a 10 year span, he led DePuy Spine, a Johnson & Johnson company, as Vice President of Sales, U.S. President and finally, Worldwide President. During his tenure, DePuy Spine grew to approximately $1 billion in global sales, operating in over 50 countries, making it the world’s second largest spinal implant company. Prior to Johnson & Johnson, Mr. Fender led the U.S. sales organization for Synthes (USA), the industry leader in orthopedic trauma, orchestrating a five year period of sales force expansion and accelerated growth. Most recently, Mr. Fender served as Vice President and General Manager for Osiris Therapeutics, Inc., the global leader in adult mesenchymal stem cell technologies. In less than two years, he built Osiris’ Osteocel business from scale-up to one of the world’s leading commercialized cellular products, which has treated over 15,000 patients to date.
“We are very pleased to have attracted Earl into the VertiFlex organization. His prior experiences in building a successful and sizable global spinal business, and both direct and independent sales organizations, make him uniquely qualified to lead VertiFlex through its next phases of growth,” said Keegan Harper, Chairman of VertiFlex’s Board of Directors. Mr. Harper went on to say, “With the most recent FDA clearance of the Dynabolt™ Dynamic Stabilization and the upcoming IDE trial for the Superion™ Interspinous Spacer, Earl joins the company at an opportune time. VertiFlex is at a great advantage with his expertise of taking products into unchartered markets and building successful organizations.”
“I am honored and excited to be associated with VertiFlex and its team of talented professionals,” said Mr. Fender. “VertiFlex’s current products, and near-term product pipeline, are highly innovative and quite differentiated from those now available in the market. I am impressed with the significant and positive surgeon response to date, and am confident that VertiFlex will continue to gain momentum, in partnering with surgeons to treat patients suffering from severe spinal disorders.”
About VertiFlex
Founded in 2005, VertiFlex, Inc. is a privately held venture-backed medical device company headquartered in San Clemente, California and operating both in the U.S. and globally. The company is dedicated to the development and advancement of minimally invasive and motion preservation technologies for disorders of the spine. VertiFlex is committed to delivering advanced products that transform patient outcomes, and offers a full compliment of solutions for minimally invasive lumbar fusion of the spine. These include the Silverbolt MLR Screw System, which allows for multi-level minimally invasive or mini-open screw fixation, the Octane VBR and the Oracle Expandable Retractor. VertiFlex’s product line also includes the Dynabolt Dynamic Stabilization System, a pedicle screw-based motion system delivered through the Silverbolt system, and the Superion Interspinous Spacer. These motion preservation product offerings allow for an array of solutions for multiple indications. The Superion Interspinous Spacer is currently under clinical investigation in the U.S. For more information on the Superion clinical trial or any of the other VertiFlex products, please contact Kathryn Larson, Marketing Manager at info@vertiflexspine.com or 949-940-1400.
Contact:
VertiFlex, Inc. Kathryn Larson, Marketing Manager, 949-940-1400 info@vertiflexspine.com
Source: VertiFlex, Inc.
